Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits

The pharmacokinetics of florfenicol and its active metabolite florfenicol amine were investigated in rabbits after a single intravenous (i.v.) and oral (p.o.) administration of florfenicol at 20 mg/kg bodyweight. The plasma concentrations of florfenicol and florfenicol amine were determined simultan...

Full description

Saved in:
Bibliographic Details
Published inJournal of veterinary pharmacology and therapeutics Vol. 30; no. 1; pp. 32 - 36
Main Authors PARK, B.-K, LIM, J.-H, KIM, M.-S, HWANG, Y.-H, YUN, H.-I
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.02.2007
Blackwell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The pharmacokinetics of florfenicol and its active metabolite florfenicol amine were investigated in rabbits after a single intravenous (i.v.) and oral (p.o.) administration of florfenicol at 20 mg/kg bodyweight. The plasma concentrations of florfenicol and florfenicol amine were determined simultaneously by an LC/MS method. After i.v. injection, the terminal half-life (t₁/₂λz), steady-state volume of distribution, total body clearance and mean residence time of florfenicol were 0.90 ± 0.20 h, 0.94 ± 0.19 L/kg, 0.63 ± 0.06 L/h/kg and 1.50 ± 0.34 h respectively. The peak concentrations (Cmax) of florfenicol (7.96 ± 2.75 μg/mL) after p.o. administration were observed at 0.90 ± 0.38 h. The t₁/₂λz and p.o. bioavailability of florfenicol were 1.42 ± 0.56 h and 76.23 ± 12.02% respectively. Florfenicol amine was detected in all rabbits after i.v. and p.o. administration. After i.v. and p.o. administration of florfenicol, the observed Cmax values of florfenicol amine (5.06 ± 1.79 and 3.38 ± 0.97 μg/mL) were reached at 0.88 ± 0.78 and 2.10 ± 1.08 h respectively. Florfenicol amine was eliminated with an elimination half-life of 1.84 ± 0.17 and 2.35 ± 0.94 h after i.v. and p.o. administration respectively.
Bibliography:http://dx.doi.org/10.1111/j.1365-2885.2007.00809.x
ArticleID:JVP809
istex:F5F40C985011B12B350590F8371F8C1EAE31C3E0
ark:/67375/WNG-R0XH3W03-6
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0140-7783
1365-2885
DOI:10.1111/j.1365-2885.2007.00809.x